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Drinking infusions of Melissa officinalis (Moff, “lemon balm”) or Bahuinia forficata (Baf, “cow´s 
hoof”) are clinically contraindicated in hypothyroidism (HypoT). However, it is not known whether they 
interfere in the cardiac response to coronary dysfunction. So, the aim of this work was to evaluate 
whether these plants interfere with the cardioprotection of HypoT after ischemia/reperfusion (I/R) in 
rats. In this model, HypoT was induced in rats by drinking methimazole for 15 days. Euthyroid (EuT) and 
HypoT rats drunk either Moff or Baf infusion during 7 days. Isolated perfused hearts were exposed to 
20 min I/45min R inside a calorimeter, a model of stunning without infarct. Contractile pressure 
development (P, mmHg), diastolic pressure (LVEDP) and total heat rate (Ht, in mW/g) were measured. 
In EuT, Moff improved the postischemic contractile recovery (PICR) (105.0±16.4% of initial vs 69.4±6.0% 
in non-treated, p<0.05) and muscle economy (P/Ht). Baf slightly reduced PICR (40.4±6.7%) and 
significantly increased LVEDP. In HypoT hearts, Moff and Baf drastically reduced PICR (54.7±3.3% and 
12.5±5.3% respectively vs 92.6±5.2% in non-treated, both p<0.05) as well as P/Ht, while increased LVEDP. 
Cyclosporine-A reversed the Moff dysfunction but not that of Baf, which was neither reduced by 
diazoxide. Results show that under HypoT Moff induced the opening of mPTP which reduce 
postischemic recovery, and Baf worsened the dysfunction although it was not related to mitochondrial 
calcium overload. Results suggest that the use of these plants in hypothyroid individuals with risk of 
cardiac ischemic episodes requires precaution. 
 















Hypothyroidism frequently appears in 
population over 30 years old and it is considered a 
risk factor for cardiovascular mortality [1, 2]. Even 
when it is easily treated with daily oral levothyroxine 
(T4) there are some interactions with medicines 
which worsen that endocrinological alteration. 
Among these, some medicinal plants interfere with 
the TSH binding to the receptor on the thyroid gland 
and with the basal and TSH-stimulated cyclic AMP 
[3]. One of these plants is Melissa officinalis L. 
(Lamiaceae), known as “lemon balm”, which is 
frequently used in the phytotherapy of many 
countries as eupeptic, slightly sedative and 
antispasmodic, as well as for treating hypertension, 
dizziness, headache and palpitations [4, 5]. Other 
authors demonstrated in vivo inhibition of thyroid 
iodide transport, thyroid hormone secretion, and 
iodothyronine deiodination as well as antagonism to 
endogenous and exogenous TSH by extracts of M. 
officinalis [4, 6, 7]. Cardiotonic properties were also 
attributed to M. officinalis but not demonstrated [8]. 
A more recent work showed that the aqueous 
extract of M. officinalis at 50-200 mg/kg via i.p. 
induced a mild protective effect against severe 
arrhythmias consequent to episodes of cardiac 
ischemia and reperfusion in rats [9]. 
 On the other hand, one of the most used 
plants for treating type-2 diabetes mellitus in South 
America belongs to the genus Bauhinia (Fabaceae) 
popularly known as “pata-de-vaca” or “cow´s hoof”. 
The most commonly cited species is Bahuinia 
forficata L., whose leaves have the flavonoids 
kaempferitrina, kaempferol-3-O-α-diraminoside and 
the steroid sitosterol as the hypoglycemic active 
components [10, 11, 12]. It is widely distributed in 
semitropical and temperate regions of Brazil, 
Paraguay and Argentina, as well as in Africa [13]. The 
genus Bauhinia comprises 300-350 species, and it 
has been divided into 9 genera based on 
phylogenetic data, all of them with poliphenols and 
antioxidant properties [14]. B. forficata has been 
cited as a medicinal plant candidate to give thyroid 
hormone analogs according to ethnobotanical 
research in Salvador-Bahia, Brazil [12], as well as by 
the in vitro inhibition of thyroid peroxidase enzyme 
to about a half [15].  
Drinking infusions of leaves from M. 
officinalis or B. forficata was contraindicated in 
hypothyroid patients because they potentiate the 
clinical endocrinological alteration [7]. Moreover, it 
is commonly thought that hypothyroidism is a risk 
factor for the cardiac diseases such as angor. The 
subclinical hypothyroidism in patients with cardiac 
diseases increased the mortality, but this was 
controlled by levothyroxine administration [2]. 
However, it was reported that hypothyroidism 
reduces the incidence of acute episodes of coronary 
syndrome in hospitalized patients of angor [16]. It is 
widely known that hearts reduce pressure 
development as a consequence of a short ischemic 
episode, and this condition is called “stunning”. 
Accordingly, results from our laboratory showed 
that hypothyroidism improved the contractile 
recovery of isolated rat hearts exposed to no-flow 
ischemia and reperfusion (I/R) [17, 18]. So, the aim of 
this work was to evaluate whether these two 
medicinal plants have any effect on the 
postischemic cardiac stunning in interaction with 
the hypothyroidism, and which was the associated 
mechanism. 
Methods 
Ethical approval  
The research was conducted in accordance with 
the internationally accepted principles for 
laboratory animal use and care as was 
recommended in the Guide for Care and Use of 
Animals (NIH Nro publication # 85-23 revised in 1985 
and 1996, National Academy Press, Washington DC, 
USA), according to the Resolution 1047 anexo II of 
Consejo Nacional de Investigaciones Científicas y 
Técnicas (CONICET) de la República Argentina, 
2005). The protocols were approved by the 
Laboratory Animals Care Commitee (CICUAL) of 
Facultad de Ciencias Exactas, Universidad Nacional 
de La Plata (Nr. 015-2015, approved on August 2015). 
Wistar rats were maintained in biotery with ad 
libitum food and water, and cycles light/dark 12 hs/12 
hs. 
Plant material and extracts 
Leaves of both plants were obtained from a local 
herboristery, Melissa officinalis (Herboplata S.R.L., 
Argentinian Public Health certification 697/01) and 
Bauhinia forficata L. (Herbores S.R.L. lote 816/B, 





Argentinian Public Health certification 12002-
27007-130) and identified by MSc Agr. Ing. Martha 
Colares in the Herbarium of the Universidad 
Nacional de La Plata. Infusions of leaves from both 
plants were prepared at 5% w/v for oral 
administration. 
Characterization of plant extracts  
Preparation of samples 
The extract for chromatographic assays was 
prepared from 1 gram of leaves (Melissa officinalis or 
Bahuinia forficata) in contact with 10 ml methanol 
during 5 minutes in a water bath at 60°C, and then 
filtered.  
Chromatographic conditions 
Samples were analyzed using a Dionex Ultimate 
3000 UHPLC (Thermo Scientific, CA, USA) 
configured with a dual gradient tertiary pump (DGP-
3000) and a DAD-3000 diode array detector. The 
stationary phase was a Thermo RP-8 column (250 x 
4.6 mm, 5 µm, Thermo Scientific, USA) and the 
mobile phase was a 85:10:5 mixture of water : 
tetrahydrofuran : methanol adjusted to pH = 3 with 
phosphoric acid. The system was operated 
isocratically at room temperature. Flow rate was set 
at 1 ml/min, and the detection was performed at 264 
nm. The extracts were diluted 1:2 with mobile phase 
and filtered through a 0.45 µm nylon membrane 
filter (13 mm, Osmonics Inc., USA) prior to their 
injection by triplicate (20 μl). 
Qualitative analysis of the samples 
Stock solutions of reference standards of gallic 
acid, chlorogenic acid, catechin, caffeic acid, 
isovitexin, rutin, vitexin and hyperoside were 
prepared in methanol. Then, adequate volumes 
were combined and diluted with mobile phase to 
yield a combined standard solution with 
approximate concentrations of 65, 10, 50, 30, 20, 20 
and 10 mg/l, respectively. 
Chromatography peaks present in the samples 
were confirmed by comparing their retention time 
and DAD spectra (200 – 400 nm) with those of the 
combined standard solution. 
Pharmacological studies 
In vivo treatments  
Hypothyroidism (HypoT) was induced by adding 
methimazole (0.02%) in drinking water for 15 days in 
adult Wistar rats of either sex (230 to 280 g weight), 
while other rats were used as euthyroid controls 
(EuT). Hypothyroidism was tested by measuring the 
T4 free and TSH levels in blood of some of the rats 
before the ex vivo experiment. 
Infusions 5% of Melissa officinalis or Bahuinia 
forficata leaves were orally administered ad-libitum, 
instead of drinking water, during 7 days to either 
euthyroid and hypothyroid rats (during the second 
week of methimazol treatment). After those 
periods, the experiment of isolated heart was 
performed as previously described. 
Isolated heart preparation and contractile 
measurements 
Wistar rats were heparinized (non-fractioned 
heparine 2000 IU) and anesthetized with 
pentobarbital overdose (60 mg/kg via i.p.) and 
tramadol (10-20 mg/kg via s.c.). Rats were 
spontaneously breathing during the general 
anesthesia, while the heart was rapidly excised. 
Retrograde perfusion was applied through coronary 
arteries by the Langendorff method, with control 
Krebs (C) at 37 °C and at a constant flow rate of 7 
ml/min by gram, by a peristaltic pump (Gilson 
Minipuls, France), as previously described [19, 20]. 
The experimental conditions (working temperature, 
heart rate and I/R periods) were similar to those of 
previous models of cardiac stunning in rat hearts, 
without a significative infarct [20, 21]. Atria and the 
spontaneous beating were removed, and a latex 
balloon was introduced in the left ventricle, 
connected by a cannula to a Bentley DEL900 
pressure transducer. While continuously perfused, 
the ventricles were introduced into the chamber of 
a flow calorimeter for little hearts, which was closed 
and submerged in a water bath kept at controlled 
temperature [19]. Ventricles were electrically 
stimulated with 5 V-5 ms at 3 Hz, by means of two 
electrodes connected to an electrical stimulator 
(Letica LE12406, Spain). The isovolumic left 
intraventricular pressure (LVP) was continuously 
recorded at optimal volume, as well as the total heat 
rate signal (both in mV) by a PowerLab 2/26 two 
channels digital acquisition system (AD Instruments, 
Australia). The LVP signal was calibrated in mmHg, 
and maximal pressure development (P) of a 





contraction was calculated from the difference 
between LVP peak and the diastolic level or left 
ventricular end diastolic pressure (LVEDP). During I 
and R there were calculated the changes in diastolic 
pressure over the preischemic condition in Krebs-C 
(ΔLVEDP), as an estimation of diastolic contracture. 
Also, during I/R, the maximal pressure developed in 
contraction was expressed as a percentage of the 
steady initial P. 
Calorimetrical measurements    
The calorimeter was previously described [19, 22, 
23]. The internal chamber has two ceramic modules 
with 127 thermosensitive units (Melchor 
Thermoelectrics, USA) each one, which detect 
changes in temperature between the inside (heart) 
and the outside (bath). Calibration and 
calorimetrical base lines in the abscence of heart 
and the presence and absence of perfusion were 
done as described before [19, 24]. The calorimeter 
was submerged in a water bath at 37.0 ± 0.01 ºC in 
connection with other two baths which respectively 
control temperature and warm the perfusates. 
Cardiac heat output was recorded simultaneously to 
the signal of LVP in the same acquisition system. The 
total heat rate (Ht) of ventricle was calculated from 
that difference between cardiac signal and the base 
lines, and finally expressed in mW/g of wet weight. 
Moreover, the ischemic and post-ischemic 
measurements were expressed as a percentage of 
the steady initial Ht. Also, total muscle economy was 
calculated as the P/Ht ratio. 
Experimental protocols 
After about 40 min of stabilization with Krebs-C, 
an initial control value of P and Ht was recorded. 
Then hearts were exposed to different treatments 
followed by a period of 20 minutes of no-flow 
ischemia (I) and 45 minutes of reperfusion (R) in a 
model of moderate stunning, previously 
characterized [20, 21, 24].  
Rats were distributed in the following basic 
treatment groups: control euthyroids (EuT, n = 7), 
control hypothyroids (HypoT, n = 5), euthyroids 
drinking Melissa officinalis (EuT-Moff, n = 4), 
euthyroid drinking Bauhinia forficata (EuT-Baf, n = 
4), hypothyroids drinking Melissa officinalis (HypoT-
Moff, n = 5), hypothyroids drinking Bauhinia forficata 
(HypoT-Baf, n = 4). 
In order to understand whether cardiac 
dysfunction was associated to opening of the 
mitochondrial permeability transition pore (mPTP) 
0.2 µmol/l cyclosporine-A was perfused during 15 
minutes before ischemia and during reperfusion [25] 
in isolated hearts of two groups (HypoT-Moff-Cys-A, 
n = 4, and HypoT-Baf- Cys-A, n = 4). Moreover, in 
order to block the sarcorreticular Ca2+ leak by the 
RyR2, 100 µmol/l tetracaine [26] was perfused 
during 5 minutes before ischemia and then 
reperfused with Krebs-C in a group of EuT-Baf -
Tetrac (n= 4). The role of mKATP channels was 
evaluated by perfusing hearts of EuT-Baf group with 
30 µM diazoxide (EuT-Baf -Dzx, n= 4) before 
ischemia and then reperfused with Krebs-C. As a 
positive control, EuT hearts were also perfused with 
30 µM diazoxide (EuT-Dzx, n= 4) before I/R as a 
cardioprotective.  
Solutions and drugs  
Hearts were perfused with Krebs-C (in mM): 1 
MgCl2, 125 NaCl, 0.5 NaH2PO4, 7 KCl, 2 CaCl2, 25 
NaHCO3, and 6 dextrose, bubbled with 95% O2-5% 
CO2. Methimazole (Sigma-Aldrich, St Louis, MO, 
USA) was dissolved to 0.02% w/v in drinking water. 
Cyclosporine-A (Cys-A, Fluka, Sigma-Aldrich, USA) 
was prepared in DMSO at 0.2 mM and diluted to 0.2 
µM in Krebs-C. Tetracaine hydrochloride (Sigma-
Aldrich, USA) was prepared at 0.1 mM solution in 
Krebs. Diazoxide (Sigma-Aldrich, USA) was prepared 
at 30 mM in DMSO and diluted in Krebs-C to 30 µM. 
All the drugs were diluted from their stock solutions 
or directly in Krebs-C at the moment of the 
experiment. In chromatographic assays all solvents 
used were HPLC grade. Standard compounds used 
in HPLC were: gallic acid (Merck, Darmstadt, 
Germany), chlorogenic acid, catechin, caffeic acid, 
isovitexin, rutin, vitexin and hyperoside (Sigma-
Aldrich, USA). 
Statistical analysis  
Results were expressed as mean ± SEM. Multiple 
comparisons by two-way ANOVA for repeated 
measures (factors were treatment and time) were 
done for the respective groups of experiments. 
Tukey post-tests were done among the treatments 
when a significant difference was found by ANOVA, 
and their results are shown in each figure. Always a 
significance level of p < 0.05 was considered. All 





statistical analyses were performed by using the 
Graph Pad Prism v.4 software.  
Results 
Chromatographic characterization of the plant 
extracts 
Although the aim of this work was not to analyze 
in detail the phytochemistry of these plants, the 
general chromatographic profile was determined as 
a characterization. Figure 1 shows the 
chromatograms of the combined standard solution 
(a), Melissa officinalis extract (b) and Bauhinia 
forficata extract (c). Based on the identification 
criteria described (retention time and UV spectra), 
the presence of caffeic acid (peak #4) and rutin 
(peak #6) could be detected in the Melissa officinalis 
extract, while a high peak not identified by a 
standard suggests the presence of an isoflavanone 
(peak #9) according to the respective UV spectra 
[27, 28]. In Bauhinia forficata extract there were 
identified low quantities of vitexin (peak #7). 
According to the respective UV spectra, the main 
peaks not identified by standards suggest the 
presence of flavanones (peaks #10 and #11).  
Effects of Melissa officinalis in euthyroid rat 
hearts 
Control euthyroid rat (EuT-C) hearts developed an 
initial P of 95.0 ± 5.6 mmHg and Ht of 22.7 ± 1.5 
mW/g. As usual, the 20 minutes period of no-flow 
ischemia reduced both, P and Ht, up to about zero 
while the diastolic tone was reduced. During the 
first minutes of reperfusion (R) the diastolic tone 
(ΔLVEDP) increased and then was gradually reduced 
(Fig. 2a). At 45 minutes R, P recovered up to 69.3 ± 
6.0% of preischemic (Fig. 3a), and Ht recovered to 
89.1 ± 6.0% of initial. In EuT-Moff rats, the hearts 
(initial P of 71.3 ± 4.6 mmHg and Ht of 14.0 ± 0.4 
mW/g) increased their postischemic recoveries of P 
(to 105.0 ± 11.6%, p<0.05 vs EuT-C rats, Fig. 3a) and Ht 
(to 99.5 ± 3.3% of initial) with about the same 
reversible increase in the ΔLVEDP (Fig. 2a). 
Moreover, EuT-Moff increased the total muscle 
economy (P/Ht) during R respect to EuT-C hearts 
(Fig. 3b). 
Effects of Melissa officinalis in hypothyroid rat 
hearts 
Control hypothyroid rat (HypoT-C) hearts 
developed an initial P of 74.5 ± 9.1 mmHg and Ht of 
14.9 ± 0.8 mW/g. As usual, the no-flow ischemia 
reduced P (Fig. 3c) and Ht. The diastolic tone was 
increased at the end of I but it was reversed during 
R (Fig. 2b). Comparing to EuT-C, the HypoT-C hearts 
recovered more the post-ischemic P and Ht, up to 
105.0 ± 11.6% (Fig. 3c) and 107.7 ± 18.7% of initial, 
respectively at 45 minutes R. However, the hearts 
from HypoT rats which orally received Moff (initial P 
of 79.7 ± 3.7 mmHg and Ht of 15.9 ± 0.9 mW/g) 
reduced the post-ischemic contractile recovery 
(PICR) to 54.7 ± 4.4% of initial P (p<0.05 vs HypoT-C 
rats, Fig. 3c) and maintained the Ht recovery up to 
101.2 ± 4.8% of initial. Consequently, Moff reduced 
the recovery of total muscle economy (P/Ht) during 
R in HypoT hearts (Fig. 3d). Perfusion of Cys-A to 
HypoT- Moff hearts (initial P of 79.7 ± 4.3 mmHg and 
Ht of 15.0 ± 0.8 mW/g) improved the recoveries of P 
and P/Ht (Figs. 3c and 3d) although increased the 
diastolic contracture respect to the HypoT-Moff 
group (Fig. 2b). 
Effects of Bahuinia forficata in euthyroid rat 
hearts 
The oral treatment of EuT rats with Baf (initial P 
of 76.6 ± 11.0 mmHg and Ht of 14.0 ± 2.6 mW/g) 
reduced the PICR of isolated hearts to 45.1 ± 10.4% 
(p<0.05 vs control rats, Fig. 4a) and maintained 
recovery of Ht up to 93.6 ± 17.0% of initial. The total 
muscle economy (P/Ht) was also reduced during R 
(Fig. 4b) and the diastolic contracture was increased 
during both I and R (Fig. 2a). The dysfunction of Baf 
was not reduced by perfusing hearts with 100 µM 
tetracaine (initial P of 65.0 ± 2.4 mmHg and Ht of 
19.5 ± 0.1 mW/g) or with 30 µM diazoxide (initial P of 
52.9 ± 17.2 mmHg and Ht of 12.2 ± 2.5 mW/g), 
because P and P/Ht remained low (Fig. 4a and b) and 
the diastolic contracture high (Fig. 2a). 
Effects of Bahuinia forficata in hypothyroid rat 
hearts 
The oral treatment of hypothyroid rats with Baf 
(initial P of 76.7 ± 12.7 mmHg and Ht of 11.9 ± 2.1 
mW/g) also reduced the contractile recovery of 
isolated hearts to 12.0 ± 5.3% (p<0.05 vs control 
HypoT rats, Fig. 4c) and Ht to 96.5 ± 13.6% of initial at 
the end of R. The P/Ht ratio was also reduced during 
R (Fig. 4d) and the diastolic contracture was 





increased (Fig. 2b). The dysfunction of Baf in 
HypoT rats was not reduced by perfusing hearts 
with Cys-A (initial P of 57.2 ± 5.4 mmHg and Ht of 9.6 
± 1.2 mW/g) (Figs. 2b, 4c and 4d). 
 Discussion 
Results show that hypothyroid rats which drunk 
the acqueous crude extracts of Melissa officinalis or 
Bahuinia forficata suffered worsening of cardiac 
stunning during reperfusion, while in euthyroid rats 
M. officinalis was cardioprotector. Although these 
results are preclinical and not directly extrapolated 
to humans, they suggest having precaution in the 
use of these medicinal plants in patients of coronary 
disease and hypothyroidism. However, this work 
also suggests that drinking infusions of Melissa 
officinalis could be beneficial in euthyroid patients of 
coronary insufficience.  
Our results show that oral administration of Moff 
to euthyroid rats (EuT) during one week improved 
the post-ischemic contractile recovery (PICR) and 
the muscle economy (P/Ht) (Fig. 3a-b). These results 
suggest that Moff has good cardiac properties when 
the thyroid state is normal, and agree with the only 
two reports about the cardiac properties of this 
aromatic medicinal plant traditionaly used for 
gastrointestinal and anxiety diseases. One report 
described that Melissa officinalis induced 
bradycardia in rats without changing the contractile 
force [8], and the other showed a mild protective 
effect against severe arrhythmias consequent to 
episodes of cardiac ischemia and reperfusion in rats 
[9]. Our study gives information about the 
contractile and energetic performance of the 
reperfused hearts in rats which received Moff 
during a subacute period of one week. The Moff-
dependent increases in both, muscle economy 
(P/Ht) and contractile recovery, suggest that 
mitochondrial metabolism was improved and 
coupled to the cardiac demand. Other report has 
also shown that Melissa officinalis extract produces 
vasodilation dependent of endothelial nitric oxide, 
and rosmarinic acid, ester of caffeic acid, was one of 
the vasodilator compounds present in it [29]. 
Although our aim was not to identify the 
phytochemical components, because they had been 
previously described [30, 31, 32], the HPLC 
characterization let us to identify two compounds 
(caffeic acid and rutin) and suggested the presence 
of a flavanone. This finding would be in accordance 
with previous studies that described the presence of 
the flavanone hesperidin [30] and the flavonoid 
luteolin-3´-glucuronide [31] as important 
constituents of M. officinalis. Others reported also 
the presence of antioxidant triterpens in M. 
officinalis, such as ursolic, carnosic and oleanolic 
acids [33]. Both, the vasodilator and antioxidant 
activities of flavonoids and triterpens could 
contribute to protect heart from I/R dysfunction and 
maintain the mitochondrial metabolism. In fact, it 
was found that the M. officinalis extract reduces the 
lipid peroxidation [34]. Moreover, flavonoids 
demonstrated to be cardioprotective against I/R 
with mechanisms such as calcium influx blockade, 
mitochondrial K+ channels activation and 
metabolism stimulation, which consequently reduce 
the mitochondrial calcium overload [35].  
On the other hand, the group of HypoT rats 
drinking Moff reduced contractile recovery (Fig. 3c) 
and increased diastolic contracture (ΔLVEDP) with 
respect to the HypoT group (Fig. 2b). Consequently, 
the muscle economy (P/Ht) was reduced, 
suggesting a great energetic cost to maintain the 
contractile performance (Fig. 3d). We have 
previously described that HypoT hearts improve 
PICR and muscle economy (P/Ht) respect to the EuT 
hearts, by mechanisms which attenuated the 
mitochondrial Ca2+ overload [17, 18]. It is well known 
that cardiac ischemia reduces the ATP level, and so 
it reduces the cytosolic Ca2+ extrusion. Under 
reperfusion, the sarcorreticular Ca2+ is lost to cytosol 
when free H+, Na+ and Ca2+ are accumulated when 
the ATP level is gradually restored from metabolism 
[36]. Those events become in a diastolic contracture 
and slow recovery of systolic contraction (PICR) 
with high energy released. Those alterations were 
prevented by hypothyroidism, with a lower 
mitochondrial Ca2+ overload [17, 18]. Results of Moff 
on postischemic HypoT hearts suggests that this 
extract further increased the cytosolic [Ca2+] during 
I/R (increase in LVEDP), so compromising the 
energetic metabolism (reduced P/Ht). It is also 
known that in severe conditions of ischemia, 
mitocohondria suffer Ca2+ overload and the opening 
of the permeability transition pore (mPTP) [37]. 
When this happens, mitochondria lose part of their 





constituents and cell become in metabolic 
energetical collapse, increase in cytosolic Ca2+, 
diastolic contracture and reduction of contractility. 
This dysfunction of HypoT rats drinking Moff 
infusion involved the activation of the mitochondrial 
permeability transition pore (mPTP), since 
cyclosporine-A (Cys-A) improved P and P/Ht. This 
mechanism was also described in other conditions 
of I/R [25].  
B. forficata would also be contraindicated in 
hypothyroid patients [12]. Our results in both, EuT 
and HypoT rat hearts showed that drinking Baf 
infusion worsened the mechano-energetical 
performance during I/R (Figs. 2 and 4). The great 
increase in diastolic contracture suggest a cytosolic 
Ca2+ overload, by which it was suggested that the 
opening of mPTP could be responsible of 
dysfunction. However, the fact that dysfunction in 
HypoT-Baf rat hearts was not avoided by perfusing 
Cys-A suggests that it was not due to the mPTP 
opening. Alternatively, the diastolic contracture 
could be due to a sarcorreticular Ca2+ leak [26], but 
this hypothesis was also rejected because the 
inhibition of RyR2 channels with 100 μmol/l 
tetracaine did not attenuate the dysfunction in EuT-
Baf rat hearts. Another possibility was that Baf 
induces the mitochondrial Ca2+ overload and 
metabolic disruption with depolarization, thus 
worsening the myocardial dysfunction during I/R. To 
evaluate this hypothesis, EuT rat hearts were 
perfused with diazoxide (Dzx) before I/R. This drug 
opens the mitochondrial K+ channels (mKATP) and 
consequently increases the mitochondrial potential 
(ΔΨm) in a way that reduces the Ca2+ influx through 
the mitochondrial Ca2+ uniporter [38, 39]. However, 
results showed that Dzx neither prevented the post-
ischemic mechano-energetical dysfunction triggered 
by Baf, suggesting that mitochondrial Ca2+ overload 
was not the origin of dysfunction. It would be 
possible that another mechanism related to the 
reactive oxygen species (ROS) production underlies 
the Baf effect, because it is a frequent cause of 
severe injury and infarct [40, 41]. The strong fall in 
P/Ht suggests that Baf induced a mitochondrial 
energetical uncoupling during R, because the 
metabolism (sensed as Ht) increased more than 
contractility (P). The uncoupling reduces the ATP 
synthesis, and consequently affects the cytosolic 
Ca2+ removal, generating diastolic contracture. 
Moreover, SERCA activity and sarcorreticular Ca2+ 
content are reduced, as well as the Ca2+ transients 
and contractility. Considering the phytochemistry of 
Bahuinia infusions, it was also reported the presence 
of flavonoids, β-sitosterol, proanthocyanidines and 
fatty acids of 18 C, steroids and polyphenoles as 
kaempferitrin [14, 42, 43]. All of them have been 
described as antiinflammatory [44] and antioxidants 
among other activities [14, 43]. Moreover, 
kaempferitrin seems to be responsible of the 
antidiabetic effect [45]. The chromatographic 
profile obtained here for B. forficata was consistent 
with the presence of several flavonoids in the 
extract. However, it was reported that the leaves 
have cytoplasmatic inclusions of calcium oxalate as 
druse formate [45], coumarins and tanins [46], 
which could cause the negative cardiac effects of 
the extract. In fact, it was shown that the extract of 
B. forficata was cytotoxic against FO-1 cancer cells, 
although it was non-toxic against Artemia salina and 
normal human lymphocytes [47]. 
Conclusions 
This work shows that drinking infusions of Melissa 
officinalis was preventive of the stunning induced by 
cardiac I/R in euthyroid rats but increased the post-
ischemic dysfuntion in hypothyroid rats, due to 
activation of the mitochondrial mPTP and Ca2+ 
overload. Contrarily, drinking infusions of Bahuinia 
forficata increased dysfunction in both euthyroid 
and hypothyroid rat hearts, and such mechano-
energetical dysfunction was not associated to Ca2+ 
overload. These results give pharmacological basis 
to the clinical precaution of using these medicinal 
plants in patients with coronary disease and 
hypothyroidism. 
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Figure 1. High-performance liquid chromatography profiles of the combined standard solution (a), Melissa officinalis (b) 
and Bauhinia forficata (c) extracts. Peak numbers corresponding to standard compounds: (1) Gallic acid; (2) Chlorogenic acid; 
(3) Catechin; (4) Caffeic acid; (5) Isovitexin; (6) Rutin; (7) Vitexin; (8) Hyperoside. UV spectra of the identified peaks and those 
























Figure 2. Effects of treatments with oral 5% infusion of Melissa officinalis (Moff) and Bahuinia forficata (Baf) on the changes in 
diastolic pressure (ΔLVEDP) suffered by isolated hearts from euthyroid (EuT, a) and hypothyroid (HypoT, b) rats exposed to 
I/R, at the following times: 5 min I, 20 min I, 5 min R and 45 min R. Moreover, the effects of perfusing the following drugs: 0.2 
µmol/l cyclosporine-A (Cys-A), 100 µmol/l tetracaine (Tet) or 30 µmol/l diazoxide (Dzx) are shown. Two-way ANOVA: by 
treatment: F = 68.54 in (a) and 13.86 in (b); by time: F = 26.67 in (a) and 9.09 in (b), all p < 0.0001; Tukey´s tests: * p < 0.05 vs 


















Figure 3. Effects of oral treatment with 5% infusion of Melissa officinalis on the cardiac pressure development (P) and the 
total muscle economy (P/Ht) during ischemia and reperfusion (I/R) of euthyroid rats (EuT-Moff) versus non-treated EuT rats 
(EuT-C) (a and b), and in hypothyroid rats (HypoT-Moff) in the absence and the presence of 0.2 μmol/l cyclosporine-A 
perfusion (HypoT-Moff-Cys-A) versus non-treated hypothyroid rats (HypoT-C) (c and d). See two-way ANOVA in Table 1; 
Tukey´s tests: * p < 0.05 vs EuT-C in (a/b) and * p < 0.05 vs. HypoT-C in (c/d), # p < 0.05 vs HypoT-Moff; n is in brackets in each 














Figure 4. Effects of oral treatment with 5% infusion of Bahuinia forficata on the cardiac pressure development (P) and the 
total muscle economy (P/Ht) during ischemia and reperfusion (I/R) in euthyroid rats (EuT-Baf), in the absence and the 
presence of 100 μmol/l tetracaine (EuT-Baf-Tet) or 30 μmol/l diazoxide (EuT-Baf-Dzx) versus non-treated (EuT-C) rats (a and 
b); and in hypothyroid rats (HypoT-Baf) in the absence and the presence of 0.2 μmol/l cyclosporine-A (HypoT-Baf-Cys-A) vs 
versus non-treated HypoT-C rats (c and d). See two-way ANOVA in Table 2; Tukey´s tests: * p < 0.05 vs EuT-C in (a/b) and * p < 
0.05 vs. HypoT-C in (c/d), # p < 0.05 vs HypoT-Baf, n is in brackets in each group in (a) and (c). 
 
 
 
 
